KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.
<h4>Background</h4>Monoclonal antibodies directed against the epidermal growth factor receptor (EGFR) have been approved for the treatment of patients with metastatic colorectal carcinoma (mCRC) that do not carry KRAS mutations. Therefore, KRAS testing has become mandatory to chose the m...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2011
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/87fffbc73bfa46eb9c3567483e04245e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|